Hormonal contraception: recent advances.
Szarewski
Anne
A
Margaret Pyke Centre, London.
D003267:Contraception; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000627:therapeutic use*; D017135:Desogestrel / Q000627:therapeutic use; D004338:Drug Combinations; D005003:Ethisterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D009644:Norgestrel / Q000031:analogs & derivatives / Q000627:therapeutic use; D010091:Oximes / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000139:chemically induced / Q000517:prevention & control; D016387:Women's Health
D003271:Contraceptive Agents, Female; D004338:Drug Combinations; D010091:Oximes; D009644:Norgestrel; D016912:Levonorgestrel; D017135:Desogestrel; D017258:Medroxyprogesterone Acetate; D005003:Ethisterone; C449219:norelgestromin